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Abstract 	  
Glutamine amidotransferases (GATs) use glutamine as a nitrogen source for a 
diverse array of biosynthetic processes. GATs hydrolyze glutamine in a glutaminase 
domain and transfer ammonia to various acceptor substrates in a synthase domain. 
Allosteric regulation plays a large role in the mechanisms of GATs. Substrate binding 
induces structural changes to both the synthase and glutaminase domains, contributing 
to product formation. Capturing these structural changes is a challenge in 
understanding the mechanisms of GATs. This thesis investigates two different GATs: 
pyridoxal 5’-phosphate synthase (PLPS) from the bacterium Geobacillus 
stearothemophilus and cytosine triphosphate synthetase (CTPS) from the bacterium 
Aquifex aeolicus.  
PLPS generates pyridoxal 5’-phosphate (PLP) from glutamine, ribose 5-
phosphate (R5P) and glyceraldehyde 3-phosphate (G3P). The mechanism of PLP 
formation was probed by solving crystal structures in three distinct states that capture 
two covalent intermediates of the synthase active site and one of the glutaminase active 
site. The structures reveal a complex set of conformational changes that sequester the 
active sites from bulk solvent. Key roles were identified for several charged amino acids.  
CTPS converts uridine triphosphate (UTP) to cytosine triphosphate (CTP) 
through ATP-activated amination of UTP. GTP serves as an allosteric activator of CTPS, 
increasing glutaminase activity 3-4 fold when glutamine is the nitrogen source. To 
	   xi 
investigate the GTP binding site I used X-ray crystallography, negative-stain electron 
microscopy and binding experiments to monitor the structural changes induced by GTP. 
The basis for CTPS inhibition by excessive GTP was established.  
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Chapter 1  
Introduction  
Glutamine Amidotransferases 
The glutamine amide group is a major source of nitrogen for the biosynthesis of 
amino acids, purine and pyrimidine nucleotides, amino sugars, and coenzymes as it is 
transferred to acceptor substrates in a variety of biosynthetic pathways1. Glutamine 
amidotransferases (GATs) are responsible for sequestering, transferring and 
incorporating nitrogen from glutamine to a variety of products. GATs are a diverse group 
of enzymes that have two active sites: a glutaminase active site hydrolyzes glutamine to 
ammonia, and glutamic acid and a synthase active site (synthetase, in the case where 
ATP activation is required) where ammonia is combined with acceptor substrates to 
generate a product (Fig. 1.1)1,2.  While ammonia alone can serve as the nitrogen donor 
for most GATs, ammonia is less effective than glutamine as a nitrogen source1.  
Utilizing glutamine not only provides an amino group for a variety of biosynthesis 
pathways, but also links carbon and nitrogen metabolism3. Glutamine synthetase is 
responsible for the condensation of ammonia and glutamate and is the only enzyme 
that incorporates ammonium ions into organic compounds. Additionally, glutamate can 
be converted to α-ketoglutarate, a key intermediate in the Krebs cycle, through oxidative 
deamination using glutamate dehydrogenase. These anaplerotic reactions replenish the 
Krebs cycle reserve of α-ketoglutarate, regulate the concentration of the cell’s favored 
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nitrogen source (glutamine), and balance the cell’s amino acid pools. Regulating α-
ketoglutarate levels plays a role in extending lifespan and delaying ageing in 
Caenorhabditis elegans4.  
	  
Figure 1.1 Simplified scheme of the overall GAT reaction and the known products 
produced by GATs.  
 
The bi-enzyme functionality of GATs is accommodated through multiple domains 
on a single polypeptide or separate interacting subunits. Channeling is an absolute 
requirement for GATs due to the lability of NH3 and the distance between their distinct 
active sites, which ranges from 10 Å to 40 Å 5. This range is due to the variation in 
architecture among GATs. The mode for opening and closing the channel and the 
specific path of ammonia transfer for most GATs has been left to speculation due to the 
limits of structural analysis. In addition to ensuring the arrival of ammonia at the 
synthase active site, the channel from the glutaminase active site to the synthase active 
site must protect the ammonia from conversion to non-reactive ammonium ion5.  
Allosteric regulation plays a large role in the mechanisms of GATs6,7. GATs 
require synchronization of the glutaminase and synthase active sites to ensure that all 
substrates are consumed at the same rate. The accepted paradigm for this regulation is 
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that glutaminase activity is dependent on the presence of synthase substrates or the 
formation of the intact protein1,8. To achieve this level of regulation, GATs have a 
defined order of substrate binding. Deciphering the mechanism behind this order is 
therefore imperative to understanding how the products are formed6,7. Additionally, 
substrate binding plays a large role in regulation: as each substrate binds to the enzyme, 
the structures of both the synthase and glutaminase domains experience 
conformational changes that contribute to catalysis6,7,9. Capturing these structural 
changes is the most challenging aspect of understanding the mechanisms of GATs. 
GAT Classifications: 
GATs are categorized exclusively by their glutaminase domain, which belong to 
four different groups: Triad GATs (class I), N-terminal nucleophile (Ntn) GATs (class II), 
amidases, and nitrilases (Table 1.1). These classifications are based on their catalytic 
residues and motifs, protein folds, and the way they recognize glutamine1,10,11. Triad 
GATs and Ntn GATs encompass most of the GATs studied thus far. The amidase and 
nitrilase groups each contain only one known GAT. The synthase domain, mechanism 
of ammonia incorporation and final product from each GAT are diverse1,2.  
Class I: Triad GATs.  
Triad GATs are characterized by an α/β fold and three invariant catalytic 
residues: cysteine, histidine and glutamate10. The catalytic triad, located at one end of 
the core β-sheet of the glutaminase domain, drives glutamine hydrolysis in a 
mechanism very similar to serine or cysteine proteases10. The α/β fold of these proteins 
is that of α/β hydrolyses with the characteristic feature of a tight α/β connection, also 
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known as the ‘nucleophile elbow’ with the cysteine nucleophile lying at the elbow 
junction10. The nucleophilic cysteine is part of a Gly-Xaa-Cys-Xaa-Gly motif while the 
catalytic His and Glu are part of a His-Pro-Glu motif1. The backbone nitrogens of the 
residue immediately following the nucleophilic cysteine and a residue located on an 
adjacent β-strand constitute an oxyanion hole that helps to stabilize the negative charge 
on the tetrahedral intermediate5. The domain architecture of Triad GATs is highly 
variable. The glutaminase and synthase domains can be either on one polypeptide, or 
on interacting subunits1.  When contained on one polypeptide, the domain order varies1.  
Class II: N-terminal nucleophile (Ntn) GATs.  
Ntn GATs are part of the Ntn hydrolase superfamily that catalyzes a diverse 
range of hydrolytic reactions11,12. The glutaminase and synthase domains are invariably 
located on a single polypeptide with the glutaminase domain located at the N-terminus1.  
Ntns have a cysteine nucleophile as the first amino acid of the mature enzyme and 
share a similar α/β core structure comprised mainly of antiparallel β-strands5,11,12. The 
oxyanion hole for the tetrahedral intermediate is stabilized by the conserved residues 
Asn and Gly that are adjacent in sequence1. 
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Table 1:1 List of GAT classifications and examples.  
 
Amidases and nitriliases. 
The amidase and nitriliase GAT families each include only one GAT. Most of the 
members of the amidase family hydrolyze aliphatic amides and are distinguished from 
other hydrolases by a Ser-cisSer-Lys catalytic triad and a distinct fold13,14. Amidases 
also contain a “GGSS motif” of ~130 amino acids that is glycine-, alanine- and serine-
rich, also known as the amidase signature14-16. GatCAB is the only example of an 
amidase GAT. GatCAB is a heterotrimeric enzyme containing an amidase glutaminase 
subunit (GatA), a synthetase subunit (GatB) and a structural subunit (GatC)17,18. 
GatCAB is responsible for converting the incorrectly acylated bacterial tRNAs (Glu-
tRNAGln and Asp-tRNAAsn) to the cognate one by amidating the misacylated tRNA 
substrate.  
Found in both prokaryotes and eukaryotes, NAD+ synthetase is the only known 
example of a GAT in the nitrilase family19. The glutaminase domain and synthetase 
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domain are located on the same polypeptide for this GAT class20. The N-terminal 
glutaminase domain is comprised of a central β-sandwich surrounded by α-helices21. 
Proteins within this family share a conserved Glu-Lys-Cys catalytic triad19,21.  
GATs are important examples of enzymes that employ two active sites to 
catalyze a two-step biochemical reaction. The activities of GATs span many facets of 
biosynthesis, contributing to the vast differences among the GATs and the increasing 
interest in this group of enzymes. These differences include their synthase 
domains/subunits, oligomeric state/architecture, substrates, mechanisms and final 
products. Structural studies have proved to be imperative in providing insights into how 
GATs function and have exposed the importance of structure to the function of each 
GAT. Surprisingly, these insights revealed similarities across different pathways and 
demonstrated how structure is essential to understanding the mechanism for each GAT.  
Crystallography allows researchers to examine the complexity of these bi-
catalytic proteins, further clarifying the large role that allosteric regulation plays in their 
function1. Due to the complexity of multi-step catalysis, it is difficult to obtain the entire 
picture of the overall reaction from a single structure model. Therefore multiple “snap 
shots” of these proteins with different combinations of bound substrates are the most 
effective way to understand the overall mechanism behind these synchronized 
complexes. My thesis project has been to take an in depth look into two different Triad 
GATs: pyridoxal 5’-phosphate synthase (PLPS) from the bacterium Geobacillus 
stearothemophilus and cytosine triphosphate synthetase (CTPS) from the 
hyperthermophilic bacterium Aquifex aeolicus.   
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Pyridoxal 5ʹ-Phosphate Synthase 
PLP 
Vitamin b6 consists of three different vitamers: pyridoxal, pyridoxamine and 
pyridoxine (Fig. 1.2). The overall structure of each of these vitamers includes a core 
pyridine ring containing 2-methyl, 3-hydroxyl and 5-hydroxymethyl substituents. The 
substituent at the 4ʹ position differs among the three vitamers. To be converted into its 
biologically active form, each vitamer is phosphorylated at the hydroxymethyl. The 
carbaldehyde at the 4ʹ of pyridoxal 5ʹ-phosphate (PLP) is responsible for its ability to 
bind to both enzyme (through a Schiff base) and substrate to stabilize reaction 
intermediates. Stabilization occurs through the extremely efficient ability of PLP to 
absorb or delocalize the excess electron density on a deprotonated reaction 
intermediate (Fig. 1.3). 
	  
Figure 1.2 The three vitamin b6 vitamers. The substituent at the 4ʹ position 
determines the biological activity of each vitamer. The aldehyde of pyridoxal 
gives this vitamer the highest biological activity (red). 
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PLP-dependent enzymes participate in reactions involved in amino acid 
metabolism, gluconeogenesis and lipid metabolism22-24. It is estimated that 1.5% of 
prokaryotic genes encode for PLP dependent enzymes, prompting the interest in 
targeting the prokaryotic PLP biosynthetic pathway as a mode for generating antibiotics 
and/or antifungals25,26. PLP-catalyzed reactions include: transamination, 
decarboxylation, racemization, elimination or replacement of an electrophilic group, and 
phosphorolysis23,27.  
	  
Figure 1.3: Example of PLP as an electron sink, stabilizing intermediates for a 
racemase reaction.  
In addition to its role as a co-factor, PLP also exhibits antioxidant properties, as it 
can quench singlet oxygen radicals through its pyridine ring and hydroxyl and amine 
substituents28-30. The antioxidant properties of PLP make the PLP biosynthetic pathway 
essential to the fungus Cercospora nicotianae, the plant pathogen producer of 
cercosporin, a photo-activated toxin29,31. The resistance of the fungus to cercosporin, 
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which is necessary for its pathogenicity, is dependent on its ability to generate PLP32.  
Therefore, targeting the PLP biosynthetic pathway in fungi provides a potential 
antifungal. Overall, understanding the role of PLP in nature and the biosynthetic 
pathway responsible for its generation is key to taking advantage of all the potential 
antibiotic and antifungal properties.   
De Novo PLP Biosynthetic Pathways 
 Two de novo pathways exist for the generation of PLP, the deoxyxylulose 5-
phosphate (DXP) dependent pathway and the DXP-independent pathway (Fig. 1.4). 
The DXP-dependent pathway was the first pathway identified and has been studied 
extensively. Discovered in Escherichia coli, this pathway consists of two branches and 
seven enzymatic steps33. The substrates for this pathway are D-erythrose 4-phosphate 
(pentose phosphate pathway), glyceraldehyde 3-phosphate (glycolysis) and pyruvate 
(glycolysis)33. This pathway is found only in gamma proteobacteria, and, despite the 
original speculation, is not the most common pathway for PLP biosynthesis31.  
 The DXP-independent pathway was identified indirectly. Originally thought to be 
predominately involved in fungal resistance to photosensitizing toxins, it was later 
revealed that the gene, PDX1, responsible for this phenotype is conserved in all 
domains of life (bacteria, archaea, eukarya) and is involved in PLP synthesis31-33. This 
led to the discovery of a second linked gene involved in this “novel” PLP biosynthetic 
pathway, named PDX234,35. Sequence alignments classified this protein (Pdx2) to the 
family of Triad GATs32. It was also determined that the nitrogen found in PLP is derived 
from glutamine, consistent with the involvement of a GAT family enzyme34,36,37. Ribose 
5-phosphate (R5P) and glyceraldehyde 3-phsophate (G3P) were identified as the 
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synthase acceptor substrates38-40. This “novel” PLP biosynthetic route is interesting due 
to its simplicity of one enzyme and three readily available substrates, which are 
common to the primary metabolism of the cell. These characteristics are thought to be 
the reason why the DXP-independent pathway is more widespread than the DXP-
dependent pathway.  
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Figure 1.4: The two pathways of pyridoxal 5ʹ-phosphate (PLP) biosynthesis33.  	  
PLPS 
Homologs of the Pdx1 synthase and Pdx2 glutaminase from many organisms 
have been identified and reconstituted31,35,41-46. Pdx1 (Bacillus subtilis) homologs 
include YaaD (Thermotoga maritima), Snz1 (Saccharomyces cerevisiae) and PdxS 
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(Geobacillus stearothermophilus), and Pdx2 (B. subtilis) homologs include YaaE (T. 
maritima), Sno1 (S. cerevisiae) and PdxT (G. stearothermophilus). This thesis concerns 
PLPS from G. stearothermophilus and the PdxS/PdxT nomenclature and amino acid 
sequence numbering will be used throughout. The structure of the intact PLPS enzyme 
is well understood and conserved among homologs9,47-51. Pyridoxal 5ʹ-phosphate 
synthase (PLPS) is a D6-symmetric complex of 12 synthase subunits (PdxS; 32kDa) 
and 12 glutaminase subunits (PdxT; 25kDa) (Fig.1.5). PdxS forms a cylindrical 
dodecamer of two opposing interdigitating hexameric rings that stack to give the overall 
shape of a barrel48. Each monomer of PdxS possesses the classic (β/α)8 barrel fold 
consisting of 8 parallel β-strands that alternate with 8 α-helices48. PdxS contains a 
handful of modification helices that are non-canonical to the (β/α)8 barrel fold, that either 
participate in the interactions with adjacent monomers or decorate the C-terminal side of 
the (β/α)8 barrel fold. The overall architecture of the D6 PdxS core is a barrel of 
perpendicular barrels. PdxS structures have been reported from B. subtilis9, S. 
cerevisiae50, T. maritima49, G. stearothermophilus48 and P. falciparium51. A C-terminal 
tail of 14-28 amino acids is disordered in all the structures. PdxT binds to PdxS in a 1:1 
ratio in which 12 PdxT subunits surround the PdxS stacked rings like studs, each 
interacting with one PdxS partner48. PdxT binds to the N-terminal side of the (β/α)8 
barrel fold of PdxS. 
PdxT has the classic α/β fold of a Triad glutaminase domain1,47,52. The core of 
PdxT is made up of a central 7-stranded β-sheet that is predominantly parallel47. The 
central β-sheet is sandwiched between six helices and two small β-sheets: one sheet 
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contains two parallel adjacent strands and one anti-parallel β-strands, while on the other 
side of the central β-sheet lies two antiparallel β-strands47,52.  
PdxS and PdxT carry out the synthase and glutaminase reactions, respectively8. 
PdxT is responsible for glutamine hydrolysis, which is carried out by the conserved 
catalytic triad (Cys78, His169 and Glu171) and the conserved oxyanion hole (Gly46 and 
Ala79)9. Structural rearrangements facilitated by PdxS-PdxT complex formation and the 
presence of glutamine lead to a peptide flip between residues Gly45 and Gly46, 
allowing the Gly45 amide to form the oxyanion hole9. This explains why PdxT lacks 
glutaminase activity in the absence of PdxS53. Unlike any other GAT studied to date, 
PLPS glutaminase activity is not dependent on the presence of the synthase substrates; 
it is contingent only on formation of the intact enzyme8.  The ammonia generated by 
PdxT is channeled to PdxS where it is combined with R5P and G3P to generate PLP8,40. 
The synthase activity is significantly more efficient when glutamine is the nitrogen 
source54,55.  
In spite of the overall simplicity of the DXP-independent pathway, the mechanism 
of PdxS is elusive and largely unknown. Understanding substrate order and the 
intermediates formed throughout the reaction is imperative in attempting to dissect the 
mechanism of PdxS. PdxS catalyzes a complicated and fascinating set of reactions to 
form PLP from three substrates, R5P, NH3 and G3P. The first synthase intermediate 
discovered was a covalent attachment between R5P and an active site lysine 
concomitant with the loss of water40. The identity of the modified lysine was 
controversial. Initially the covalent adduct was detected on Lys149 by peptide analysis 
using MS-MS, but the first structure of PLPS co-crystallized with R5P revealed the 
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attachment at Lys8140,49. Both lysines are invariant. Initially believed to be an imine 
between the active site lysine and R5P, it was identified through 13C labeling and 1-
dimensional NMR experiments that R5P is attached through C1 to the lysine as an 
amino ketone (Fig. 1.6)56.  
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Figure 1.5 Organization of PLPS 24-mer A. The synthase subunit (PDB: 2ISS, T. 
maritima; orange and green) of PLPS forms a cylindrical dodecamer. B. The 
glutaminase subunit (blue and purple) binds to the synthase subunit (orange and 
green) like studs. C. The catalytic protomer includes one synthase monomer 
(orange) and one glutaminase monomer (blue). D. Lys81 in the synthase subunit 
is the site of Schiff base formation with R5P (Lys81; orange ball-and-stick, R5P; 
gray ball-and-stick). The glutaminase catalytic triad consists of a Cys78, His169 
and Glu171 (yellow ball-and-stick). 
Further investigation led to the discovery of a second covalent intermediate on 
the path to PLP55. Formation of this chromophoric intermediate is dependent on the 
presence of R5P and ammonia55. Analysis of this new intermediate determined a strong 
A.
B.
C.
90°
90°
90°
D.
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UV absorption at 315 nm. Biochemical assays and mass spectrometry revealed that the 
chromophoric adduct is generated after the amino ketone has undergone dehydration, 
loss of inorganic phosphate and incorporation of ammonia54-57. Additionally, 
chromophore formation requires the C-terminal 30 amino acids of the synthase subunit, 
which are disordered in all published structures6. Where G3P binds to the synthase 
subunit, how G3P combines with the chromophore adduct and why the C-terminal tail of 
the synthase subunit is crucial to function are essential missing pieces from the puzzle 
in understanding the overall mechanism of PdxS.  
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Figure 1.6 PLP biosynthesis catalyzed by PLPS. Ammonia generated by 
glutamine hydrolysis in PdxT is channeled to the PdxS active site where it joins 
R5P and G3P to form PLP by an unknown mechanism that proceeds through two 
sequential covalent intermediates. First, R5P and PdxS (Lys81) form a Schiff base 
that isomerizes to a stable amino ketone56. Dehydration, incorporation of NH3 
from PdxT and loss of inorganic phosphate convert the amino ketone to a 
chromophoric adduct54-57. The chromophoric adduct is then combined with G3P 
to form PLP. 
 
Cytidine Triphosphate Synthetase 
CTP 
 Cytidine triphosphate (CTP) is a pyrimidine nucleotide and one of the four 
nucleotide building blocks of RNA. For DNA synthesis, CTP is dephosphorylated to 
cytidine diphosphate (CDP), which is then reduced by ribonucleotide reductase to 
deoxy-cytidine diphosphate (dCDP), which is phosphorylated to dCTP. Additionally, 
CTP is the precursor for phospholipid pathway intermediates such as cytidine 
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diphosphate diacylglycerol (CDP-DG), CDP-choline and CDP-ethanolamine58,59. CDP-
DG provides the phosphatidyl moiety for phosphatidylserine, phosphatidylethanolamine, 
phosphatidylcholine, phosphatidylglycerol, cardiolipin and phosphatidylinositol60,61. 
CDP-choline and CDP-ethanolamine provide the hydrophilic head groups for 
phosphatidylethanolamine, and phosphatidylcholine (Fig. 1.7)61.  
	  
Figure 1.7 The role of CTP synthetase in the synthesis of phospholipids. 
 
 RNA, DNA, and phospholipids are essential to cell proliferation. Therefore, 
understanding the biosynthetic pathway for CTP provides a useful target for cancer 
treatment. Cancer cells have elevated and unregulated levels of CTP biosynthesis, 
demonstrating how important and directly correlated CTP biosynthesis is to 
oncology62,63. Cancer cells differ from normal cells in their use of the rapid oxygen-
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independent pathway of glycolysis to produce the cell’s energy, known as the Warburg 
effect64. Glycolysis generates the building blocks for nucleotides (ribose 5-phosphate) 
and phospholipids (glycerol), which are necessary for cell replication and tumor 
maintenance65.  
CTP Biosynthesis 
 The biosynthesis of CTP through amination of uridine triphosphate (UTP) was 
first discovered in Escherichia coli (Fig. 1.8)66. The pathway is dependent on ammonia, 
adenosine triphosphate (ATP), magnesium and UTP and is the only biosynthetic route 
to CTP66. Further characterization revealed that CTP formation is most efficient with 
glutamine as the nitrogen source (although ammonia can substitute) and is tightly 
regulated by other nucleotides: guanosine triphosphate (GTP) is a potent activator and 
the product, CTP, is a potent inhibitor67-70. GTP activation is observed only when 
glutamine is the nitrogen source71.  
	  
Figure 1.8 CTP biosynthesis 
 
The enzyme responsible for generating CTP, CTP synthetase (CTPS), was 
purified first from E. coli and identified as a homotetramer, with each monomer 
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containing all the necessary active sites needed to convert UTP to CTP67,72. Although 
the active enzyme complex is a homotetramer, it has been shown that at low CTPS 
concentrations and in the absence of nucleotide substrates, CTPS will dissociate to a 
dimer73-75. The mechanism of CTPS proceeds through phosphoryl activation of UTP at 
the O4 position in the presence of ATP and Mg+2, creating the attack site for NH3, 
ending in the release of phosphate, CTP and ADP7,74. Further investigation revealed 
that CTPS is a GAT, and forms a glutamyl-thioester intermediate during the reaction 
mechanism76. Glutaminase activity is dependent on the presence of the acceptor 
substrates (UTP and ATP), as it is for most GATs74.  
Nucleotides not only affect the oligomerization of CTPS, but also its activity. 
CTPS exhibits positive cooperativity for each of UTP and ATP when the concentration 
of the other is limiting67,73. Under saturating concentrations, binding of UTP and ATP 
occurs in a Michaelis-Menten manner67,73. CTPS glutaminase activity is increased 3-4 
fold in the presence of GTP7,77. GTP accelerates the glutamylation of CTPS, increasing 
the kcat and decreasing the Km of this step, while having no effect on the NH3-mediated 
CTP formation71. Kinetic studies suggest that GTP increases the affinity for and 
stabilization of the tetrahedral intermediate of glutamine hydrolysis78. The concentration 
range for GTP activation is very narrow. Concentrations exceeding 0.15 mM GTP inhibit 
CTP formation while having no effect on glutaminase activity, indicating that the 
nucleotide may bind competitively to the other nucleotide binding sites79.  
At high concentrations, CTP acts as a competitive inhibitor67. CTP was 
speculated to occupy the same binding site as UTP67, however, a crystal structure of 
CTPS co-crystallized with CTP revealed that this was only partially true77. The UTP and 
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CTP triphosphate binding sites overlap, whereas the nucleosides occupy two binding 
sites that differ by a rotation of ~120° 77,80. This prevents UTP and CTP binding to CTPS 
at the same time and prevents wasteful generation of CTP. The intricate role of each 
nucleotide concentration in regulating CTPS activity ensures that nucleotide 
concentrations are maintained in proper balance. Deregulation of CTPS abolishes the 
cell’s natural checkpoint allowing the overproduction of CTP, which leads to the 
overproduction of phospholipids, DNA and RNA, supporting excessive cell 
proliferation62,63,81. In addition to being a target for cancer therapy, CTPS has been 
shown to play a role in the human immune system. A mutation was identified that 
resulted in an impaired capacity of activated T and B cells to proliferate in response to 
antigen receptor–mediated activation81. These results suggest that CTPS may also be a 
target for auto- or allogenic-specific T-cell and B-cell therapies81.   
CTPS 
 CTPS is conserved across both eukaryotes and prokaryotes. Yeast and 
mammals have two isoforms of CTPS82-84. In mammals these isoforms share 74% 
identity84. The gene for CTPS from E. coli encodes 544 amino acids, whereas that from 
yeast encodes 570 amino acids82,85. CTPS is comprised of an N-terminal synthetase 
domain followed by an interdomain linker and a C-terminal class I Triad glutaminase 
domain85,86. The CTPS tetramer has an overall X shape with D2 symmetry (Fig. 1.9). 
The synthetase domains interact, supporting the core of the complex, while the 
glutaminase domains form arms of the X86,87.  
The glutaminase domain is made up of a core seven-stranded parallel β-sheet, 
with the exception of β6, which is antiparallel to the rest. On one side of the core β-
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sheet are two antiparallel β-strands and five α-helices86,87. On the other side there are 
three β-strands, two parallel and one antiparallel, and five α-helices86,87. The conserved 
catalytic triad includes residues Cys378, His502, and Glu50485-87. The backbone 
amides of Gly349 and Leu377 make up the oxyanion hole87.  
The synthetase domain is composed of a core β-sheet consisting of 7 parallel β-
strands, which is sandwiched between helical layers with 5 α-helices on each side86,87. 
ATP binds within a single subunit, and a hydrogen bond to the N6 adenine base creates 
nucleotide specificity by preventing GTP from binding to this site77,80. UTP binds 
between subunits, with the uracil base contained within the same subunit as ATP, and 
the triphosphate binding to the adjacent subunit77. The triphosphate of CTP binds to the 
same site as the UTP triphosphate while the sugar-base is rotated around the C4ʹ -C5ʹ 
bond and positioned in a cleft created by three different subunits77,80. The GTP binding 
site is unknown. Many attempts to elucidate this binding site and determine how GTP 
binding influences glutaminase activity have been unsuccessful.  
Thesis Overview 
The focus of this thesis is to elucidate key residues/structural elements that 
contribute to the multi-step catalysis of two Triad GATs (PLPS from G. 
stearothermophilus and CTPS from A. aeolicus).  In this study I am interested in 
investigating the structural changes induced by either binding of the acceptor substrates 
or binding of an allosteric activator and determining which amino acids propagate the 
conformational changes that are essential to the mechanism. X-ray crystallography was 
used to study structures of each protein with covalent intermediates, providing 
snapshots of the enzyme in its catalytic cycle. Mutagenesis, enzyme kinetics and 
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biochemical assays were used to investigate specific sites deemed to be critical to a 
definitive step in each enzyme’s mechanism.  
 To investigate the mechanism and the role of the C-terminal tail of the synthase 
subunit (PdxS) of PLPS, three crystal structures were obtained with either the synthase 
subunit alone (PdxS/R5P and PdxS/R5P/NH3) or the intact protein (PLPS/R5P/Gln).  
These structures represent the three different known intermediates generated during 
the catalytic cycle. Each intermediate was trapped using either site directed 
mutagenesis and/or biochemical assays to optimize the conditions specific to each 
intermediate. Structural elements that experienced conformational changes were 
probed by site-directed mutagenesis to identify which residues are important and how 
they affect mechanism.  
 To elucidate the GTP binding site on CTPS and identify how binding enhances 
glutaminase activity, X-ray crystallography, mutagenesis and biochemical assays were 
used to probe the individual domains and the intact CTPS homotetramer. I obtained a 
structure of CTPS co-crystallized with a glutamine analog (6-diazo-5-oxo-L-norleucine; 
DON) to promote the binding of GTP with a Michaelis-Menten complex of CTPS. 
Biochemical assays were used to probe each domain individually to determine where 
GTP binds.  
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Figure 1.9 Overall architecture of CTPS. A. CTPS homotetramer77. The 
overall shape of CTPS is an X with D2 symmetry. B. TOP: The glutaminase 
domains (colored) generate each arm of the overall X shape. BOTTOM: The 
synthetase domains (colored) interact, supporting the core of the complex. 
C. Each monomer is comprised of a N-terminal synthetase domain (red) 
followed by an interdomain linker (gray) and ending with a C-terminal 
glutaminase domain (pink). 	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Chapter 2  
Structural Investigation into the Mechanism of the Synthase Subunit of PLPS. 
Summary 
PLP synthase (PLPS) generates the highly utilized co-factor pyridoxal 5'-phosphate 
(PLP), from common readily available cell metabolites (glutamine, ribose 5-
phosphate (R5P) and glyceraldehyde 3-phosphate (G3P)). PLPS is a D6-symmetric 
complex of 12 synthase subunits (PdxS) and 12 Triad glutaminase subunits 
(PdxT). PdxT and PdxS have distinct and remote functions. PdxT functions as a 
Triad glutaminase using a Cys-His-Glu triad to hydrolyze glutamine to glutamate 
and ammonia. The ammonia is channeled to the active site of PdxS, which 
functions as a synthase combining ammonia with G3P and R5P. The mechanism 
and residues responsible for the combination of ammonia (from PdxT), R5P and 
G3P has escaped biochemical analysis. Pieces of the catalytic pathway have been 
confirmed including the identification of two covalent intermediates and substrate 
binding order. First, R5P and PdxS (Lys81) form a Schiff base that isomerizes to a 
stable amino ketone, in a manner independent of PdxT, glutamine or G3P40,56. 
Dehydration, incorporation of NH3 (from PdxT) and loss of inorganic phosphate 
convert the amino ketone to a chromophoric adduct54,55,57. To investigate the 
mechanism of the synthase subunit, I obtained two crystal structures of synthase 
complexes (PdxS/R5P and PdxS/R5P/NH3). The structures provide snapshots of 
PdxS at distinct steps in its complicated catalytic cycle and provide insights into the 
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elusive mechanism and structural elements that drive the conversion of amino 
ketone to chromophore. The structure of PdxS with R5P contains two covalent 
adducts, pentulose phosphate modifications on Lys81 and Lys149. They differ in 
attachment to R5P (C1 or C2). The unexpected adduct at Lys149 implies that 
Lys149 may play a role in either the conversion of the amino ketone to the 
chromophore or G3P binding. The structure of PdxS with R5P in the presence of 
NH3 captures three distinct states in the 12 active sites of the crystallographic 
asymmetric unit, providing snapshots of PdxS from amino ketone to chromophore 
formation. Additionally, Lys149 is flipped into the active site, as opposed to its 
position outside of the active site observed in every other structure of the synthase 
subunit. Through biochemical assays and a comparison of the two crystal 
structures, I identified residues important to the conversion of the amino ketone to 
the chromophore and a second phosphate-binding site residing outside of the R5P 
active site that appears to play a role in PLP formation post chromophore 
formation.  
Introduction 
 Pyridoxal 5-phosphate synthase (PLPS) is a single enzyme route for 
generating PLP in organisms that utilize the deoxyxylulose 5-phosphate (DXP) 
independent pathway33. PLPS is a 24-subunit enzyme comprised of two subunits, 
PdxS12 and PdxT12 (Fig. 2.1)9. PdxT functions as a Triad glutaminase domain, 
using the catalytic triad Cys-His-Glu to hydrolyze glutamine to glutamate and 
ammonia (Fig. 2.2)8. Ammonia produced in PdxT is channeled to the active site of 
PdxS where it participates in the second reaction of the bi-catalytic enzyme (Fig 
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2.3)40. PdxS functions as a remarkable synthase using simple readily available 
precursors from PdxT (NH3), glycolysis (G3P) and the pentose phosphate pathway 
(R5P) as substrates8,40. Dissecting the mechanism of the synthase subunit of PLPS 
has proven to be challenging. Biochemical analysis has revealed pieces of the 
mechanism but trying to put the pieces together has been difficult. Order of 
substrate binding and identification of covalent intermediates has been imperative 
to elucidating the step-by-step catalytic mechanism of PdxS.   
	  
Figure 2.1 Structure of PLPS. A. PLPS (PDB: 2NV2) is a 24-mer made up of 
PdxS12 (orange and green) and PdxT12 (purple and blue). B. The catalytic 
protomer consists of one monomer of PdxS (green) and one monomer of 
PdxT (purple)9. 
 
 
A.
B.
90°
90°
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Figure 2.2 PdxT functions as a glutaminase. A. PdxT hydrolyzes glutamine 
to generate glutamate and ammonia. B. PdxT (PDB: 2ISS, T. maritima; 
purple) uses a catalytic triad (His, Glu, Cys; yellow sticks) to hydrolyze 
glutamine49. 
 
PdxS binds one substrate at a time, building on an initial Schiff base 
intermediate between R5P and an active site lysine that isomerizes to form an 
amino ketone (Fig. 2.3)40,56. The presence of the amino ketone has been confirmed 
through mass spectrometry (MS) and nuclear magnetic resonance (NMR)40,55,56. 
The formation of the covalent intermediate is not dependent on the presence of 
PdxT, glutamine or G3P40. The intermediate has been observed in a crystal 
structure of PLPS from Thermotoga maritima40,49,55,56. Two different groups have 
confirmed the mass of the intermediate to be 212 Da,40,55 corresponding to the 
addition of R5P (230 Da) and loss of a water molecule (-18 Da). Initial experiments 
(trypsin digest followed by MS-MS) identified the invariant Lys149 as the site of the 
intermediate55. The role of Lys149 and the identification of the R5P carbon 
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attached to the lysine have been controversial. In contrast to the MS-MS results, 
the PLPS structure from T. maritima revealed that the lysine modified was Lys81 
and not Lys14949.  
	  
Figure 2.3 PdxS functions as a synthase. A. The mechanism of PdxS 
proceeds through two covalent intermediates40,55. B. Lys81 (yellow 
spheres) is the site of covalent attachment49. (PDB: 2ISS, T. maritima, 
green). 
 
Based on the occupancy and the steric constraints for the phosphate group 
of the pentulose phosphate adduct, the covalent adduct in the PLPS structure from 
T. maritima was modeled as a C2 attachment (Fig. 2.4)49. Although the enzyme 
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was co-crystallized with R5P, R5P and ribulose 5-phosphate (5RP) readily 
interconvert, allowing the pentose phosphate sugar to form a Schiff base either 
through C1 (a highly reactive aldehyde on R5P) or C2 (a ketone on 5RP) 
supporting the possibility for either attachment. The structure with the Lys81 adduct 
led to the hypothesis of a hand-off between Lys81 and Lys149 on the reaction 
pathway49. Kinetic experiments revealed a preference for R5P over 5RP, based on 
Km values, suggesting that a C1 attachment is preferred55. NMR experiments 
revealed that the lysine adduct is attached through C156.  
	  
Figure 2.4 The first covalent intermediate modeled as a C2 attachment in 
YaaD from T. maritima49.  
 
Based on these results, a Schiff base at Lys149 appears to be improbable. 
Nevertheless, the structure of the synthase subunit alone (Snz) from 
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Saccharomyces cerevisiae co-crystallized with PLP shows PLP bound outside of 
the synthase active site and forming a hydrogen bond with Lys14950. Once again 
the hypothesis of a Lys81 hand-off to Lys149 resurfaced, supporting the idea that 
in the process of product generation, the first covalent intermediate occurs at Lys81 
(inside the active site), somewhere along the catalytic pathway it is combined with 
G3P, and the product associates with Lys149 outside of the active site. However, 
in all reported structures of the synthase subunit or the intact PLPS enzyme, 
Lys149 is always pointed outside of the active site9,48-50.  
 The next piece of the catalytic puzzle was the identification of a second 
covalent adduct. In the presence of ammonia (more effectively when glutamine is 
the nitrogen source), the amino ketone isomer is converted to a chromophoric 
covalent intermediate with a wavelength maximum at 315 nm55. MS experiments 
revealed that the mass of this new adduct is 95 Da55. This corresponds to the loss 
of two water molecules, inorganic phosphate and the incorporation of NH354. 
Isotope experiments revealed that the release of phosphate is through a beta 
elimination resulting in a double bond between C4 and C554. NMR experiments 
identified C2 as the site of ammonia incorporation and analyzed the structure of the 
chromophore56,57.  
 The combination of G3P with the chromophore to form PLP is the remaining 
catalytic step. The binding site of G3P is still unknown. It is also unknown whether 
G3P incorporation is dependent on any catalytic residues or based solely on 
proximity and correct orientation to the chromophore. The structure of the synthase 
subunit alone (Snz) from S. cerevisiae co-crystallized with a large excess of G3P 
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shows G3P binding outside of the active site between adjacent subunits. This site 
contradicts the conventional substrate binding inside the barrel for all proteins with 
the β8/α8 fold.  
 The objective was to crystallize the synthase subunit (PdxS) with each 
covalent adduct in order to elucidate the global conformation changes associated 
with each intermediate. In order to stabilize each covalent intermediate, specific 
conditions were optimized. The resulting structures permit a greater understanding 
of the synthase mechanism and how all the pieces fit together, including identifying 
residues that participate in the conversion of the amino ketone to the chromophore, 
affirmation of the carbon attachment of R5P and a view of the structure of the 
chromophore. Additionally, I have gained insights into potential binding sites for 
G3P, leading to a more comprehensive mechanistic proposal.  
Experimental Procedures  
Cloning of G. stearothermophilus pdxS - 
The plasmid pET088148 for PdxS was used for all mutagenesis and sub-cloning. 
Some substitutions in PdxS (D24N, D24A, D102A, R147K, R147A, and R147Q) 
were generated by site directed mutagenesis (SDM) (QuikChange by Strategene). 
SDM primers are listed in table 2.1. PdxS K149 substitutions were generated by 
SDM (Table 2.1) followed by sub-cloning and insertion into an appropriate 
expression vector (K149R and K149Q cloned into pTrc-9, K149A cloned into 
pMCSG9). Primers used to sub-clone pdxS out of pET0881 are listed in Table 2.2. 
The remaining substitutions were generated by SDM on the wild type pdxS gene 
that had been sub-cloned into an appropriate expression vector Table 2.1. Dr. Clay 
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Brown constructed the pTrc-9 vector from pMCSG9 by cleaving pMCSG9 with 
restriction endonucleases Sph I and Nde I.  This removes the T7 promoter, lac 
operator and ribosome binding site sequences.  These sequences were replaced 
by insertion of a synthetic DNA carrying the trp/lac fusion promoter trc88, the 
translational enhancer sequence for the E. coli atp genes89 and the ribosome 
binding site (AGGAGG) spaced eight base-pairs from the ATG start sequence90. All 
mutagenesis was verified by sequencing.  
Table 2:1 Primers used for SDM.
 
 
Table 2:2 Primers used to sub-clone pdxS.
 
 
Expression and Purification of PdxS and PdxT: 
PdxS and PdxT were purified separately. Cells of E. coli strain BL21(DE3) (or 
strain BL21 for pPdxSMBP_K149R and pPdxSMBP_K149Q) were transformed 
with the appropriate expression plasmid, grown at 37°C in either Luria-Bertani (LB) 
Plasmid Name Mutation
Expression 
Vector Direction Primer
pET0881_D24N PdxS D24N pET0881 Forward 5'-GCGGCGTCATCATGAACGTCGTGAACGCA-3'
pET0881_D24A PdxS D24A pET0881 Forward 5'-CGGCGTCATCATGGCCGTCGTGAACGCAG-3'
pET0881_D102A PdxS D102A pET0881 Forward 5'-CTTGGTGTCGACTACATTGCCGAAAGTGAAGTATTAACG-3'
pET0881_R147K PdxS R147K pET0881 Forward 5'-AAGGGGCATCGATGTTGAAAACCAAAGGAGAGCCGG-3'
pET0881_R147Q PdxS R147Q pET0881 Forward 5'-GGGCATCGATGTTGCAAACCAAAGGAGAGCC-3'
pET0881_R147A PdxS R147A pET0881 Forward 5'-GGGGCATCGATGTTGGCAACCAAAGGAGAGCC-3'
pPdxSMBP_K149R PdxS K149R pET0881 Forward 5'-CGGCTCTCCTCTGGTTCGCAACATCGATGC-3'
pPdxSMBP_K149Q PdxS K149Q pET0881 Forward 5'-CGATGTTGCGAACCCAGGGAGAGCCGGGGAC-3'
pPdxSMBP_K149A PdxS K149A pET0881 Forward 5'-TCGATGTTGCGAACCGCAGGAGAGCCGGGGAC-3'
pPdxS_E103Q PdxS E103Q pMCSG7 Forward 5'-CCGGCGTTAATACTTCACTCTGGTCAATGTAGTCGACACCA-3'
pPdxS_E103A PdxS E103A pMCSG7 Forward 5'-GTGTCGACTACATTGACGCAAGTGAAGTATTAACGCC-3'
pPdxSMBP_H115Q PdxS H115Q pMCSG9 Forward 5'-GGCTGATGAGGAATTCCAGATTGACAAACGGCAGTTT-3'
pPdxS_H115A PdxS H115A pMCSG7 Forward 5'-GCCGGCTGATGAGGAATTCGCTATTGACAAACGGCAGTTT-3'
pPdxSMBP_R130Q PdxS R130Q pMCSG9 Forward 5'-TTTGTGTGCGGTTGCCAGGATTTAGGGGAAGCGG-3'
pPdxSMBP_R130A PdxS R130A pMCSG9 Forward 5'-CGCTTCCCCTAAATCGGCGCAACCGCACACAAAT-3'
pPdxS_R137Q PdxS R137Q pMCSG7 Forward 5'-GGGGAAGCGGCGCAGCGCATTGCAGAAG-3'
pPdxS_R137A PdxS R137A pMCSG7 Forward 5'-TTCTGCAATGCGGGCCGCCGCTTCCCCT-3'
pPdxSMBP_R138K PdxS R138K pMCSG9 Forward 5'-TGCCCCTTCTGCAATCTTGCGCGCCGCTTCCCC-3'
pPdxSMBP_R138E PdxS R138E pMCSG9 Forward 5'-GGGAAGCGGCGCGCGAGATTGCAGAAGGGGC-3'
pPdxSMBP_R138Q PdxS R138Q pMCSG9 Forward 5'-GAAGCGGCGCGCCAGATTGCAGAAGGGG-3'
pPdxSMBP_R138A PdxS R138A pMCSG9 Forward 5'-GGAAGCGGCGCGCGCCATTGCAGAAGGG-3'
pPdxSMBP_R137QR138Q PdxS R137QR137Q pMCSG9 Forward 5'-TTTAGGGGAAGCGGCGCAGCAGATTGCAGAAGGGGCATC-3'
pPdxSMBP_R137AR138A PdxS R137AR138A pMCSG9 Forward 5'-GCCCCTTCTGCAATGGCGGCCGCCGCTTCCCCTAA-3'
pPdxSMBP_K187Q PdxS K187Q pMCSG9 Forward 5'-GAGCCCCGAGCTGCTGCGCCTCAGCGACA-3'
pPdxSMBP_K187A PdxS K187A pMCSG9 Forward 5'-GAGCCCCGAGCTGTGCCGCCTCAGCGACAA-3'
Primer Name Template Direction Primer Expression Vectors
PdxS Start 3 pET0881 Forward 5'-TACTTCCAATCCAATGCAAGCACAGGTACGGAC-3' pMCSG7, pMCSG9, pTrc-9
PdxS Stop LIC pET0881 Reverse 5'-TTATCCACTTCCAATGTTACCAGCCGCGTTCTTG-3' pMCSG7, pMCSG9, pTrc-9
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or Terrific Broth (TB) medium until OD600 reached 0.8 for LB and 1 for TB. The 
temperature was reduced to 20°C for 1 hr, expression was induced with either 200 
µM (TB) or 400 µM (LB) IPTG, and cultures were incubated 12-16 hr (specifics 
listed in Table 2.3). All purification steps were carried out at 4°C unless otherwise 
noted. Cells from a 1 L culture were harvested by centrifugation, re-suspended in 
40 mL of Buffer A (20 mM Tris-HCl pH 7.9, 500 mM NaCl), lysed by sonication, and 
centrifuged at 18,000 x g. The supernatant was filtered and loaded onto a Ni+2 
affinity column (HisTrapTM HP, GE Healthcare). Bound protein was eluted with a 
linear gradient of 0-500 mM imidazole in Buffer A. The N-terminal His6-tag of PdxS 
was removed by TEV protease by 4 hr digestion at room temperature followed by 
dialysis (Buffer A). TEV protease and un-cleaved PdxS were removed by Ni+2 
affinity chromatography. Proteins intended for crystallization were further purified 
by gel filtration. PdxS was purified on an S300 column (HiPrepTM 16/60 
SephacrylTM S-300 HR, GE Healthcare) using 20 mM Tris-HCl pH 8.5, 500 mM 
NaCl, 10 mM glutamine, 2 mM DTT. PdxT was purified on an S100 column 
(HiPrepTM 16/60 SephacrylTM S-100 HR, GE Healthcare) using 20 mM Tris-HCl pH 
7.9, 500 mM NaCl, 2 mM DTT. Individual subunits were concentrated and stored at 
-80°C.  
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Table 2:3 Specific growth conditions for each construct.
 
 
PLPS Activity Assays: 
Formation of the chromophoric adduct of R5P and NH3 with PdxS was assayed at 
37°C in a total reaction volume of 50 µL containing 50 µM PdxS, 50 µM PdxT, 50 
mM Tris-HCl pH 7.9, 20 mM glutamine and 10mM R5P55. The chromophoric 
adduct was detected by absorbance at 315 nm in a SpectraMax M5.  
PLP synthesis was assayed at 37°C in a total reaction volume of 50 µL containing 
50 µM PdxS, 50 µM  PdxT, 50 mM Tris-HCl pH 7.9, 20 mM glutamine, 10mM R5P, 
20 mM G3P. PLP was detected by absorbance at 415 nm in a SpectraMax M5. 
Chromophore formation and PLP synthesis for PdxS mutants at Lys149 were 
assayed in a sub-micro quartz cuvette (Starna Cells, Inc.) with a total reaction 
volume of a 100 µL using an Ultrospec 3100 pro spectrophotometer (Amersham 
Biosciences).  
Plasmid Mutation Expression Vector Media Antibiotic [IPTG] µM
pET0881_D24N PdxS D24N pET0881 LB Kan 400
pET0881_D24A PdxS D24A pET0881 LB Kan 400
pET0881_D102A PdxS D102A pET0881 LB Kan 400
pET0881_R147K PdxS R147K pET0881 LB Kan 400
pET0881_R147Q PdxS R147Q pET0881 LB Kan 400
pET0881_R147A PdxS R147A pET0881 LB Kan 400
pPdxSMBP_K149R PdxS K149R pTRC9 TB Amp 200
pPdxSMBP_K149Q PdxS K149Q pTRC9 TB Amp 200
pPdxSMBP_K149A PdxS K149A pMCSG9 TB Amp 200
pPdxS_E103Q PdxS E103Q pMCSG7 TB Amp 200
pPdxS_E103A PdxS E103A pMCSG7 TB Amp 200
pPdxSMBP_H115Q PdxS H115Q pMCSG9 TB Amp 200
pPdxS_H115A PdxS H115A pMCSG7 TB Amp 200
pPdxSMBP_R130Q PdxS R130Q pMCSG9 TB Amp 200
pPdxSMBP_R130A PdxS R130A pMCSG9 TB Amp 200
pPdxS_R137Q PdxS R137Q pMCSG7 TB Amp 200
pPdxS_R137A PdxS R137A pMCSG7 TB Amp 200
pPdxSMBP_R138K PdxS R138K pMCSG9 TB Amp 200
pPdxSMBP_R138E PdxS R138E pMCSG9 TB Amp 200
pPdxSMBP_R138Q PdxS R138Q pMCSG9 TB Amp 200
pPdxSMBP_R138A PdxS R138A pMCSG9 TB Amp 200
pPdxSMBP_R137QR137Q PdxS R137QR137Q pMCSG9 TB Amp 200
pPdxSMBP_R137AR137A PdxS R137AR138A pMCSG9 TB Amp 200
pPdxSMBP_K187Q PdxS K187Q pMCSG9 TB Amp 200
pPdxSMBP_K187A PdxS K187A pMCSG9 TB Amp 200
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Intact Protein Mass Spectrometry 
For detection of covalent adducts of PdxS, reaction mixtures of total volume 100 µL 
were incubated 15 min at 37°C, quenched with 10% formic acid and analyzed by 
LC-MS. Samples were eluted at a flow rate of 0.5 mL/min, with a linear gradient of 
5% to 95% acetonitrile, over 15 min employing a Aeris widepore C4 column (3.6 
µm, 50 x 2.10 mm) and directly analyzed by ESI mass spectrometry (Agilent 6520 
Accurate Mass Q-TOF). Data were analyzed using the maximum entropy 
deconvolution algorithm within the Agilent Mass Hunter Qualitative Analysis 
software.  
Assays of covalent adduct formation at Lys81 in PdxS D24N, D24A, R147K, 
R147Q and R147A were carried out with 150 µM PdxS and 200 µM PdxT, 20 mM 
Tris-HCl pH 7.9, 10 mM R5P, 20 mM Gln. Assays of adduct formation in wild type 
PLPS were carried out with 31.25 µM PdxS, 60 µM PdxT, 20 mM Tris-HCl pH 7.9, 
10 mM R5P, 0-20 mM Gln. Assays of adduct formation in PdxS with various pHs 
were carried out with 31.25 µM PdxS, 10 mM R5P, 50 mM (NH4)2SO4, 20 mM Tris-
HCl pH 7.0-8.5. Assays of adduct formation in PdxS with increasing amounts of 
(NH4)2SO4 were carried out with 31.25 µM PdxS, 10 mM R5P, 0-250 mM 
(NH4)2SO4, 20 mM Tris-HCl pH 7.0. Excess substrates were removed using a gel 
filtration column (PD-10 Desalting column, GE Healthcare), and the eluate was 
diluted to 1 mg/mL total protein prior to formic acid treatment. Assays of second 
adduct formation in PdxS were carried out with 31.25 µM PdxS, 25 mM R5P, 20 
mM Tris-HCl pH 7.0. Acid-quenched samples were incubated overnight before MS 
analysis.  
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Crystallization: 
PdxS/R5P was crystallized at 20°C via sitting drop vapor diffusion using 4 µL 
protein solution (5 mg/mL PdxS, 20 mM Tris-HCl pH 8.5, 25 mM R5P, 20 mM 
MgCl2) and 4 µL reservoir solution (6% PEG 8K, 200 mM Li citrate, 100 mM Na 
cacodylate pH 7.0). Crystals appeared within 3 days, grew over 7 days, and were 
cryo-protected with 15% ethylene glycol in reservoir solution and flash-cooled in 
liquid nitrogen. 
PdxS/R5P/NH3 was crystallized at 20°C via sitting drop vapor diffusion using 4 µL 
protein solution (5 mg/mL PdxS, 20 mM Tris-HCl pH 8.5, 25 mM R5P, 20 mM 
MgCl2) and 4 µL reservoir solution (5.6% PEG 8K, 200 mM ammonium citrate, 100 
mM Na cacodylate pH 7.0). Crystals appeared within 3 days and grew over 7 days. 
Eight hours prior to harvesting, 0.8 µL of 250 mM R5P stock was added to the 
drop. Crystals were cryo-protected with 15% ethylene glycol in reservoir solution 
and flash-cooled in liquid nitrogen. 
 
X-ray Data Collection and Processing: 
Data were collected at the Advanced Photon Source (APS) on the GM/CA beam 
line 23ID-D. Data were processed and scaled with the HKL2000 suite (Table 
2.4/2.5)91. Initial phases for each structure were determined by molecular 
replacement (MR). PdxS from the PLPS/H169NT/R5P/Gln structure (Chapter 3) 
was used to solve the PdxS/R5P structure using the program phaser92,93. The 
PdxS/R5P structure was then used to solve PdxS/R5P/NH3 also using phaser93. 
Iterative model building was done in COOT94 and refinement was carried out with 
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REFMAC95. Translation/libration/screw (TLS) groups for both structures were 
determined using the webserver TLS MD96,97. Link records for the PdxS covalent 
adducts Lys81-R5P, Lys149-R5P and Lys81-chromophore were created using J 
Ligand98 while the restraints and coordinates were created using prodrg99 and the 
grade server100. The final models were validated with MolProbity101. The refinement 
statistics of the final models are summarized in Table 2.5 and Ramachandran plots 
are shown in Fig. 2.5 and 2.6.  
 
Table 2:4 Scaling statistics for PdxS/R5P and PdxS/R5P/NH3.  
 	  
Lower Upper
50.00 5.81 199 5.5 1.195 0.058 11.0
5.81 4.62 97.2 2.8 1.448 0.081 11.4
4.62 4.03 97.1 2.9 1.809 0.102 11.4
4.03 3.66 67.2 2.5 1.560 0.122 11.4
3.66 3.40 44.8 2.2 1.473 0.162 11.4
3.40 3.20 28.8 1.9 1.403 0.222 11.5
3.20 3.04 17.6 1.8 1.363 0.333 11.5
3.04 2.91 11.7 1.7 1.303 0.474 11.5
2.91 2.80 8.6 1.7 1.250 0.642 11.4
2.80 2.70 6.8 1.8 1.268 0.838 11.4
58.6 2.5 1.408 0.129 11.4
Lower Upper
50.00 4.95 362.3 16.2 1.052 0.053 3.8
4.95 3.93 290.2 13.4 1.464 0.067 3.8
3.93 3.44 159.5 8.3 1.518 0.081 3.8
3.44 3.12 84 5.5 1.263 0.096 3.8
3.12 2.90 42.4 4.1 1.317 0.152 3.8
2.90 2.73 26.6 3.7 1.317 0.219 3.8
2.73 2.59 18.7 3.6 1.246 0.296 3.8
2.59 2.48 13 3.5 1.217 0.417 3.8
2.48 2.38 9.9 3.6 1.195 0.556 3.8
2.38 2.30 7.5 3.7 1.185 0.740 3.8
102.2 6.6 1.278 0.093 3.8
PdxS/R5P
All Reflections
PdxS/R5P/NH3
Shell Limit (Å) Average I Average Error Chi2 Linear R-factor Multiplicity
All Reflections
Shell Limit (Å) Average I Average Error Chi2 Linear R-factor Multiplicity
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Table 2:5 Crystallographic data and refinement statistics for PdxS/R5P and 
PdxS/R5P/NH3.  
 
 
Synthase/R5P Synthase/R5P/NH3
Diffraction data
X-ray Source APS 23ID-D APS 23ID-D
wavelength 1.033 1.033
space group P3121 P21
unit cell parameters (Å) 179.79, 179.79, 104.57 94.68, 107.20, 178.22
α, β, γ (°) 90, 90, 120 90, 92.24, 90
asymmetric unit 6 PdxS 12 PdxS
resolution limit (Å) 2.70(2.77-2.70) 2.29 (2.35-2.29)
unique reflections 53746 158924
avg. I/σI 23.4(3.8) 15.5(2.0)
avg. multiplicity 11.4(11.4) 3.8(3.8)
completeness (%) 100(100) 100(100)
Rsym 0.129(0.838) 0.093(0.74)
Refinement 
data range 43.44-2.70 47.35-2.29
Reflections 50930 150841
R/Rfree (%) 21.8/26.2 19.4/22.5
RMS deviations
bonds lengths (Å) 0.0112 0.0072
bond angles (deg) 1.4169 1.1374
average B factors (Å2)
protein 63.2 49.1
water 46.2 48.4
ligands 77.3 67.6
Ramachandran
Favored (%) 97.4 97.5
Allowed(%) 2.5 2.3
Outlier (%) 0.1 0.2
Number of Atoms
Protein 10971 22333
Water 193 1015
Ligands 264 154
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Figure 2.5 Ramachandran plot for PdxS/R5P. Ramachandran plots for 
PdxS/R5P indicate that 97.4% of all residues were in favored regions and 
99.9% of all residues were in allowed regions. Plots were generated using 
Molprobity101. 
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Figure 2.6 Ramachandran plot for PdxS/R5P/NH3. Ramachandran plots for 
PdxS/R5P/NH3 indicate that 97.5% of all residues were in favored regions 
and 99.8% of all residues were in allowed regions. Plots were generated 
using Molprobity101. 
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Results 
First Covalent Intermediate: PdxS Forms a Pentulose Phosphate Adduct with 
R5P.   
I visualized the synthase active site with its first covalent intermediate at 
Lys81 by co-crystallization of PdxS with R5P (Fig. 2.7).  Covalent modification of 
PdxS in solution was confirmed by whole-protein mass spectrometry (MS) (Fig. 
2.8A).  The overall dodecameric structure is virtually identical to the structure of the 
free enzyme form of PdxS48.  Electron density corresponding to an R5P adduct at 
Lys81 was present in the active sites of all six subunits in the crystallographic 
asymmetric unit (Fig. 2.9A).  The Lys81 connection had clear density in five active 
sites and was ambiguous in the sixth.  The density is most consistent with 
formation of a Lys81 adduct at the R5P C1 atom, based on the appearance of 
unbiased density and the distance between the lysine amino nitrogen and the R5P 
phosphate.  This differs from the C2 Schiff base adduct reported for the T. maritima 
PLPS49, but is consistent with biochemical data56.  I modeled and refined the R5P 
adduct both as the 1-imino, 2-hydroxyl isomer and as the 1-amino, 2-keto isomer.  
The amino-keto isomer had a better fit to density, as expected56.  Lys81 is at the 
top of strand β3 in the PdxS β8/α8 barrel.  The side chain and R5P adduct extends 
~15 Å across the barrel with the phosphate near the N-terminus of helix α8'.  
Despite formation of the adduct, the active site is open perhaps due to the disorder 
of residues 49-56, which were also disordered in the free enzyme structure48.  
Other contacts of PdxS with the adduct include hydrogen bonds to phosphate 
oxygens from the amide nitrogens of Gly153, Gly214 and Gly235.  Conserved 
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Asp24 is adjacent to the C2 of the intermediate in position to participate in the 
formation and isomerization of the Schiff base to the amino ketone. I tested this 
idea with Ala and Asn substitutions (Table 2.6). The covalent adduct did not 
accumulate in either of these variants (Fig. 2.10), which also had 100-fold reduced 
chromophore and PLP formation (Table 2.6). Published results also implicated 
Asp24 in PLP synthesis9. 
	  
Figure 2.7 Capturing the First Covalent Intermediate: PdxS modified with 
pentulose phosphate amino ketone. R5P forms a covalent adduct with Lys 
81 and Lys149 (PdxS; magenta, R5P; gray sticks, Lys81/Lys149; cyan 
sticks). Salt bridge network (orange/yellow dashes) surrounding the Lys149 
5RP adduct (gray sticks). Residues that interact directly with each covalent 
adduct are shown in cyan sticks (hydrogen bonds in yellow dashes). 
 
Arg138
Arg137
Arg130
Asp24
Gly235
Lys81-R5P
Lys149-R5P
Gly85
Glu103
Glu141
Ile116 Lys118
Glu134
Gly214
Gly153
His115
C-Terminus (270)
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Figure 2.8 Doubly modified PdxS. A. Deconvoluted ESI-mass spectra of 
PdxS incubated 15 minutes with R5P yields full occupancy of the amino 
ketone intermediate. B. Deconvoluted ESI-mass spectra of PdxS under long 
incubation (48 hours with 25 mM R5P) yields the observances of a second 
adduct.  
 
A. 
B. 
Amino Ketone (32061.7 Da)
Amino Ketone (32061.7 Da)
Amino Ketone + Amino Ketone  (32273.8 Da)
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Figure 2.9 R5P adduct at Lys81 through C1 (R5P; gray sticks, Lys81; cyan 
sticks, Fo-Fc omit density contoured at 2 σ, green). 5RP adduct at Lys149 
through C2 (5RP; gray sticks, Lys149; cyan sticks, Fo-Fc omit density 
contoured at 2 σ, green). 
 
Under the conditions of crystallization, an R5P adduct also formed at 
Lys149.  I observed the doubly modified state in solution upon long-term incubation 
of PdxS with an excess of R5P (Fig. 2.8B).  Density for the adduct at Lys149 was 
best fit with a connection to the R5P C2 atom (Fig. 2.9B).  In refinement tests, the 
2-amino, 3-keto isomer at C2 (1-hydroxyl, 2-amino, 3-keto) was a better fit to 
density than were either the imine at C2 or the alternative amino-ketone at C2 (1-
A. 
B. 
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al, 2-amino, 3-hydroxyl).  When an R5P covalent intermediate was discovered40, 
Lys149 was identified as the site of the R5P adduct, but the site was reassigned to 
Lys81 in light of a structure of PLPS co-crystallized with R5P49.  The Lys149 adduct 
is unlikely to be on the reaction pathway given its long formation time.  Lys149 is at 
the top of strand β6 in the PdxS β8/α8 barrel with the side chain and R5P adduct 
directed outside the barrel away from the active site.  Interestingly, in this position 
the adduct phosphate occupies an identical site as the phosphate of product PLP 
in a crystal structure of the yeast enzyme50 and a phosphate ion in the structure of 
the PdxS free enzyme48 (Fig. 2.11).  The phosphate has ionic contacts with Arg137 
and Arg138, which is positioned in an extensive salt bridge network with Glu103, 
Lys118 and Glu141.  Catalysis was modestly affected by mutagenesis of each Arg, 
but double substitutions with Gln or Ala reduced activity tenfold (Table 2.6).  In 
contrast, substitutions at Lys149 were deleterious to chromophore formation, and 
no PLP was formed without a positive charge at this position. Glu103 was the only 
residue in the salt bridge network where substitutions maintained wild type levels of 
chromophore formation, although PLP synthesis was reduced four-fold. The C3 
hydroxyl forms a hydrogen bond to a conserved Arg130, and the C4 hydroxyl to 
conserved His115. Substitutions at Arg130 had an effect on both chromophore and 
PLP formation, while disrupting the hydrogen bonding ability at position 115 
decreased PLP synthesis modestly (Table 2.6).   
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Figure 2.10 Substitutions at Asp24 prevent the accumulation of any R5P 
adduct. A: D24N B: D24A. Spectra are deconvoluted ESI-mass specta.  
 
Free Enzyme (31848.62 Da)
Free Enzyme (31805.59 Da)
A.
B.
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Table 2:6 Initial velocity as percent wild type for PdxS variants. 
 
PdxS Variant
Chromophore 
Formation (initial 
velocity as % WT)
PLP Synthesis 
(initial velocity as 
% WT) 
D24N 2 ± 0.9 3 ± 0.5
D24A N.D. 5 ± 0.5
D102A 118 ± 5 165 ± 3.3
E103Q 97 ± 1 24 ± 1.2
E103A 103 ± 1 23 ± 10.3
H115Q 127 ± 2 78 ± 4.7
H115A 82 ± 0.6 38 ± 1.3
R130Q 18 ± 0.5 57 ± 6.5
R130A 39 ± 0.3 56 ± 2.3
R137Q 16 ± 0.9 34 ± 4.7
R137A 24 ± 0.5 53 ± 2.7
R138K 92 ± 0.9 61 ± 2
R138E 30 ± 0.6 38 ± 2.6
R138Q 25 ± 0.8 33 ± 0.8
R138A 23 ± 0.6 31 ± 0.5
R137QR138Q 6 ± 0.8 10 ± 1
R137AR137A 9 ± 1 16 ± 1.5
R147K 2 ± 1 4 ± 0.5
R147Q 0.8 ± 2.4 4 ± 3.2
R147A 4 ± 1.9 3 ± 2
K149R 4 ± 0.03 9 ± 2.3
K149Q 1 ± 0.2 N.D. 
K149A 1 ± 0.1 N.D. 
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Figure 2.11 Second phosphate binding site. Superposition of S. cerevisiae 
Snz1 structure (orange) with bound PLP (the product, green sticks) and G. 
stearothermophilus PdxS structure (magenta) with bound 5RP (gray sticks) 
and interacting residues (cyan sticks, yellow dashes). 
Second Covalent Intermediate: Amino ketone is converted to the 
chromophore. 
A chromophoric intermediate forms in the PdxS active site when ammonia 
encounters the R5P covalent intermediate54,55.  This can be accomplished by 
addition of glutamine to PLPS or by addition of ammonia to PdxS or PLPS. The 
chromophore adduct has a mass consistent with addition of NH2 to the R5P 
adduct, loss of phosphate and two waters54,55. I used intact-protein MS to identify 
conditions with maximum accumulation of the chromophore in either PdxS or 
PLPS, but all conditions yielded mixtures of the chromophoric intermediate, the 
R5P adduct and the free enzyme.  Under no conditions was the chromophoric 
Lys149-R5P
Arg138
Arg130
Arg137
PLP
	   50 
intermediate the dominant species (Fig 2.12), consistent with previous results54.   
	  
Figure 2.12 Chromophore accumulation. A. Buffers with various pHs were 
tested in an attempt to maximize the amount of chromophore. Peak areas 
are from maximum entropy deconvoluted spectra. B. Various ammonium 
sulfate concentrations were tested at pH 7 in an attempt to maximize the 
amount of chromophore. Peak areas are from deconvoluted ESI-mass 
spectra. 
 
I was unable to obtain a structure of PLPS with the chromophore, but 
replacement of Li citrate with ammonium citrate in the crystallization for the 
PdxS/R5P structure produced crystals of PdxS in a different form (Fig. 2.13). In this 
new crystal form, the twelve subunits in the crystallographic asymmetric unit 
include three states of the synthase active site: R5P adduct, chromophore and no 
adduct (Fig. 2.14). The density for the covalent adducts is poorer than for the 
surrounding protein, probably due to a mixture of states in each subunit. The 2.3 Å 
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structure is a snapshot of PdxS in transition between the Schiff base/amino ketone 
intermediate and the chromophore intermediate. 
	  
Figure 2.13 PdxS co-crystallized with R5P in the presence of NH3 contains 3 
different substrate species in the 12 active sites of the asymmetric unit. A. 
Monomer containing the amino ketone. B. Monomer containing the 
chromophore. 
 
Lys81-R5P
A. 
Lys81-Chromophore
B. 
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Figure 2.14 Amino ketone intermediate and chromophore intermediate 
interactions with PdxS. Left: The amino ketone intermediate (gray sticks) at 
Lys81 (orange sticks; residues that interact with the amino ketone; orange 
sticks, green; Fo-Fc omit density contoured at 2σ). Right: The chromophore 
(gray sticks) at Lys149 (orange sticks; residues that interact with the 
chromophore; orange sticks, green; Fo-Fc omit density contoured at 2σ). 
 
The R5P adduct is the dominant species observed in this structure. Seven 
of the twelve active sites contain density for the pentulose phosphate amino ketone 
intermediate at Lys81, two contain density for a phosphate ion, two contain density 
for the chromophore with density for a free phosphate ion and the remaining active 
site contains density consistent with five carbon atoms not covalently attached to 
Lys81 and a free phosphate ion (Fig. 2.14). Density interpreted as the 
chromophore is consistent with the length of a five-carbon planar adduct. The 
phosphate ion is clearly separated from the chromophore and remains bound to 
the same residues that interact with the phosphate group when it is still attached to 
the amino ketone intermediate.  
 R5P interacts with PdxS with many of the same residues observed in the 
Asp24
Gly235
Gly
214Lys149
Lys81 Lys81
Chromophore
PO4
-2
Asp24
Lys149
Gly
153
Gly235
Gly
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amino ketone structure. In addition to Asp24, Arg147 and Glu102 are conserved 
and form a salt bridge under the adduct. Substitutions were made at each position 
and synthase activity was assayed. Substitutions at Asp102 had a negligible effect 
on either synthase activities (Table 2.6). On the other hand, mutagenesis of Arg147 
reduced chromophore formation and PLP synthesis 100-fold. Intact-protein MS 
revealed that Arg147 substitutions prevented accumulation of the chromophore 
(Fig. 2.15). The free phosphate is bound through hydrogen bonds with the 
backbone nitrogens of Gly153, Gly235 and Gly214. In contrast to the structure of 
the first covalent intermediate, Lys149 points into the R5P active site to hydrogen 
bond with the C2 hydroxyl of the amino ketone intermediate or the C3 hydroxyl of 
the chromophore intermediate (Fig. 2.16). 
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Figure 2.15 Substitutions at Arg147 prevent the formation of the 
chromophore. A: R147Q B: R147A. Spectra are deconvoluted ESI-mass 
specta. 
 
Amino Ketone (32033.65 Da)
Amino Ketone (31976.6 Da)
Free Enzyme (31764.5 Da)
A.
B.
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Figure 2.16 Lys149 located on the invariant KGEPG loop in is a different 
position in the PdxS/R5P/NH3 structure than its position in any previously 
solved structures. (PdxS/R5P; magenta/cyan, PLPS TH169N Gln/R5P; 
red/gray, PdxS/R5P/NH3; teal/orange). 
 
Discussion  
 The studies reported in this chapter provide a deeper glimpse into the 
complex mechanism of the synthase subunit of PLPS. Covalently trapping each 
synthase intermediate provided snap-shots of the synthase subunit throughout 
parts of its catalytic cycle. From these structures I was able to observe the 
structural changes induced by the formation of each adduct within an enzyme from 
Lys81-R5P
Lys149
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a single organism and to elucidate the residues necessary to convert the amino 
ketone to the chromophore. Many mechanistic schemes have been proposed for 
the conversion of the amino ketone to the chromophore. Understanding how many 
individual observations fit together has been challenging. The results have given 
rise to three hypotheses: 1. Dissociation of the covalent intermediate after amino 
ketone formation followed by reattachment before chromophore formation56, 2. A 
second phosphate-binding site outside of the β8/α8 barrel102, and 3. A G3P binding 
site at the interface between monomers50. In order to test these hypotheses I 
sought to identify structural elements that are critical for specific steps in the 
synthase mechanism.  
 Based on the results I propose that the mechanism of PdxS is an all or 
nothing type reaction, where all the reactions necessary to convert the amino 
ketone to chromophore happen simultaneously instead of in succession. The 
structure of the amino ketone and reactivity of ammonia allow for a domino affect to 
occur that collapses the amino ketone to the chromophore with little catalytic 
assistance from the enzyme. This hypothesis is based on the inability to trap novel 
intermediates expected to be stable based on the proposed mechanisms56. 
Potential catalytic residues surrounding the R5P active site include Asp24, Asp102, 
Arg147 and Lys149 (in the case for the PdxS/R5P/NH3 structure when Lys149 is 
pointed into the active site). Among these residues, Asp24, Arg147 and Lys149 
had an effect on synthase activities. Substitutions at Asp24 prevented the 
formation of the amino ketone intermediate suggesting that Asp24 participates in 
the formation of the Schiff base and its isomerization to the amino ketone. 
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Substitutions at Arg147 terminated the pathway after amino ketone formation 
supporting its role in dehydration reactions.  
The role of Lys149 is not obvious although others and I have found that it is 
critical for chromophore and PLP formation49. The PdxS/R5P/NH3 structure is the 
first instance where Lys149 is pointed into the active site (Fig. 2.16), in all other 
cases this lysine is outside of the active site9,48-50. Two roles can be proposed for 
Lys149. The first is participation in the conversion of the amino ketone to the 
chromophore. It was proposed that the amino ketone adduct experiences a C-N 
bond shift that switches the Lys81 attachment from a C1 to C5 (Fig. 2.17)56. The 
movement of Lys149 may be induced by the presence of NH3 in the crystallization 
condition triggering its position within the active site and its participation in the 
proposed C-N bond flip. Among the twelve active sites one contains density 
consistent with five carbon atoms detached from Lys81 and a free phosphate ion. 
The second potential role involves the second observed phosphate site outside the 
active site where it may be an initial binding site for G3P. Substitutions at Lys149 
significantly affected the rate of both synthase activities (chromophore formation 
and PLP synthesis) supporting a dual purpose.  
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Figure 2.17 Proposed C-N bond shift. NMR results suggest that there is a 
bond shift during catalysis shifting from a C1 attachment for the amino 
ketone and a C5 attachment for the chromophore (green box)56.  
 
Based on the synthase structures, I propose two potential binding sites for 
G3P. The first site would be with the G3P phosphate replacing the phosphate ion 
released by chromophore formation (hydrogen bonds to Gly 153, Gly214, and 
Gly235). The free phosphate ion in the active sites with the chromophore remains 
bound to the same residues that interact with the phosphate group of the amino 
ketone intermediate suggesting that the chromophore could be bound at the same 
time that another phosphate group is bound to the P-loop. Positioning G3P in 
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proximity to the chromophore should be sufficient for the combination of the two to 
form PLP. I attempted to find amino acid substitutions that would support 
chromophore formation but block PLP formation, but no conserved residue at the 
active site had this property.  
A second more interesting hypothesis for G3P binding is that G3P forms a 
Schiff base with the invariant Lys149 and cradles in the conserved second 
phosphate binding site outside of the R5P active site. There are many lines of 
evidence that support the binding site of the second molecule of R5P as a site for 
G3P binding. First the modification made to Lys149 is a C2 attachment supporting 
the binding of a shorter molecule than R5P (Fig. 2.18). Phosphate groups, and 
sulfate ions are prone to bind to this region (Fig. 2.19)48-50. Refinement tests 
supported the attachment at Lys149 as the 2-amino, 3-keto isomer (1-hydroxyl, 2-
amino, 3-keto), consistent with the structure of G3P attached at C1. The residues 
surrounding this site are conserved and there is an extensive salt bridge and 
hydrogen bond network that propagates from the core of the enzyme to orient the 
residues directly interacting with this second molecule of 5RP. Substitutions at 
positions 103 and 115 separate the efficacy of chromophore formation from PLP 
synthesis suggesting that these residues are important for the binding/incorporation 
of G3P. The movement of Lys149 into the active site in the presence of NH3 
provides the orientation and proximity necessary for the incorporation into the 
chromophore adduct in addition to sequestering G3P, which has a higher Km than 
the other two substrates.  
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Figure 2.18 Modeled Lys149-G3P adduct. G3P (green sticks) modeled on 
Lys149 (cyan sticks), the phosphate group is in the same position as the 
C2 5RP covalent adduct.  
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Figure 2.19 Superposition of the second phosphate-binding site. 
Superposition of G. stearothermophilus PdxS/R5P/NH3 (cyan/gray sticks, 
magenta), S. cerevisiae Snz1/PLP (yellow sticks; PDB: 3O05; orange), T. 
maritima PLPS/R5P/PO4-3 (PDB: 2ISS; red) and G. stearothermophilus 
PdxS/SO4-2 (PDB: 1ZNN; green). All of the sulfate and phosphate groups 
bind to the second phosphate-binding site.   
Overall, I propose that formation of the amino ketone and the chromophore 
are the only steps in the synthase mechanism that require catalytic residues 
(Lys81, Asp24 and Arg147). Mutagenesis implicated Lys149 in both synthase 
activities. These structures reveal that Lys149 is dynamic. The position of Lys149 
is apparently an effect of ammonia. In the presence of ammonia Lys149 is 
positioned inside of the R5P active site and interacts with the chromophore. In the 
absence of ammonia Lys149 is positioned outside of the R5P active site and may 
form a covalent adduct with G3P. Each position addresses a role for Lys149 in 
both synthase activities.  
I propose two potential binding sites for G3P. The first site, in accord with 
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the conventional binding sites known to proteins with the β8/α8 fold, fits the spatial 
constraints necessary to incorporate G3P into the chromophore. The second site 
provides a biological role for the secondary phosphate-binding site and suggests a 
mechanism that proceeds through two subsequent Schiff bases on different 
residues (Lys81 and Lys149). Substitutions to residues surrounding the second 
exterior phosphate-binding site decrease, without abolishing, the efficacy of PLP 
synthesis. The mutagenesis results suggest that this site is implicated in G3P 
binding and PLP formation but not involved in chromophore formation. On the other 
hand, failure to identify residues that eliminate PLP synthesis completely without 
affecting chromophore formation supports overlapping binding sites for R5P and 
G3P, and that G3P incorporation does not require catalytic activation. 	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Chapter 3  
The Role of the C-terminal tail of PdxS 
Summary 
PLP synthase (PLPS) from the bacterium Geobacillus stearothermophilus generates 
pyridoxal 5'-phosphate (PLP), the active form of vitamin B6, from glutamine, ribose 5-
phosphate (R5P) and glyceraldehyde 3-phosphate (G3P). PLPS is a D6-symmetric 
complex of 12 synthase subunits (PdxS) and 12 Triad glutaminase subunits (PdxT). 
PdxS forms a cylindrical dodecamer of two hexameric rings48. PdxT binds around the 
outside of the PdxS stacked rings49. Ammonia, generated from glutamine hydrolysis in 
PdxT, is channeled to the PdxS synthase active site where it joins R5P and G3P to form 
PLP by an elusive mechanism that proceeds through two sequential covalent 
intermediates. First, PdxS and R5P form an enzyme-imine40, which then undergoes 
isomerization to a stable amino ketone intermediate56. Dehydration and conjugation 
upon incorporation of NH3 and concomitant loss of inorganic phosphate leads to the 
generation of a chromophoric adduct54,55. Chromophore formation and PLP synthesis 
are dependent on the presence of the C-terminal tail of PdxS, which is generally 
disordered6. Using an inactive mutant of PdxT, I co-crystallized PLPS with substrates 
glutamine and R5P. This is the first structure of PLPS with multiple substrates. Initial 
crystals with dmin ~4 Å were improved with dehydration to dmin ~ 2.7 Å. The higher 
resolution structure contains all but four amino acids of the C-terminal tail of PdxS, 
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consistent with the observed decrease in accessibility of the tail upon substrate binding6. 
The ordered C-terminal tail interacts with the body of the synthase subunit, acting as a 
shield over the R5P active site in a more closed state of the synthase subunit. 
Additionally, glutamine and R5P binding initiate conformational changes around the 
R5P active site that bury R5P into the core of PdxS. Through biochemical assays, I 
identified conserved charged residues responsible for these movements, suggesting 
that the closed state is crucial to the formation of the chromophore.  
Introduction 
 Structural studies have been critical in dissecting the mechanism of PLPS and 
connecting the results derived from biochemical studies to a catalytic mechanism. 
Structures of the heteromeric PLPS complex and the dodecameric synthase complex 
have been solved from both prokaryotic and eukaryotic microorganisms, with and 
without substrates9,48-50. All structures solved to date lack any structural information 
regarding the C-terminal tail of the synthase subunit and contain at most one substrate 
(Fig. 3.1). The range of missing C-terminal residues ranges from 14-28 amino acids9,48-
50. The structure of Thermotoga maritima PLPS co-crystallized with R5P contains the 
most C-terminal residues observed in any structure49. The increase in order is attributed 
to the covalent intermediate of the synthase subunit and R5P and additionally the 
binding of a phosphate ion to a secondary binding site on the synthase subunit49. The 
consistent disorder of the C-terminal tail led to investigation of the importance of this 
flexible segment for enzyme function6. Truncation of these residues abolished both 
chromophore formation and PLP synthesis6.  
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Figure 3.1 The active sites of the synthase subunit. A. Structures from various 
biological sources have been determined for either the synthase subunit or the 
intact enzyme (PLPS) with each substrate individually. B. Independent of the 
substrate or product, the C-terminus of PdxS is disordered (spheres). PLPS from 
T. maritima (synthase subunit; red) with R5P covalently attached (gray spheres)49. 
Synthase subunit from S. cerevisiae (orange) with PLP (gray spheres)50. Synthase 
subunit from S. cerevisiae (blue/gray) with G3P (yellow sticks)50.  
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Bacillus subtilis PLPS glutamine
PLP
G3P
Thermotoga maritima PLPS R5P
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G3PG3P
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In order to obtain an understanding of the structural role of the C-terminal tail in 
regards to the synthase activity, tryptophan quenching and proteolysis experiments 
were conducted6. Tryptophan quenching experiments revealed a decrease in 
fluorescence in the presence of the glutaminase subunit and a further decrease in the 
presence of glutamine6. Proteolysis experiments revealed that the C-terminal tail is 
protected from proteolysis in the presence of substrates and that the effect is additive in 
the presence of the glutaminase subunit and both acceptor substrates6. These results 
suggest that the synthase C-terminal tail becomes ordered in the presence of the 
glutaminase subunit and substrates, behaving in a manner similar to a lid6.  
Our objective was to crystallize Geobacillus stearothermophilus PLPS with an 
ordered C-terminal tail. In order to accomplish this, based on previously published data, 
PLPS would need to be crystallized with as many substrates bound as possible. To trap 
glutamine, the catalytic histidine (169) was mutated to an asparagine preventing the 
release of glutamate, locking the glutaminase in a acyl-enzyme intermediate (Fig. 3.2)9. 
Covalent attachment of R5P to PdxS is independent of the remaining substrates or the 
glutaminase subunit. Therefore, the ability to co-crystallize PLPS with at least two 
substrates using the inactive glutaminase mutant in the presence of glutamine and R5P 
should order the C-terminal tail of PdxS. My hypothesis is that co-crystallization of 
PLPS/H169NT with glutamine and R5P will provide structural information regarding the 
position of the C-terminal tail and its role in chromophore formation and PLP synthesis. I 
expressed PLPS with the inactive glutaminase mutant (PdxT/H169N) and co-
crystallized PLPS in the presence of Gln and R5P. This is the first structure of PLPS 
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from G. stearothermophilus and the first structure of PLPS with more than one bound 
substrate.   
	  
Figure 3.2 Glutaminase inactive variant. A. Mutating the catalytic histidine to an 
asparagine prevents the release of glutamate. B. PdxT H169N locks the glutamyl 
thioester intermediate on the nucleophilic cysteine.  
  
Experimental Procedures 
Cloning of G. stearothermophilus pdxS and pdxT- 
The plasmids pET088148 for PdxS and pET0669103 for PdxT were used for all 
mutagenesis and sub-cloning. PdxT H169N and some substitutions in PdxS (R53K, 
R53E, R53A, R53Q, E151S, E151A, E151Q, R288K, R288E, R288Q and R288A) were 
generated by site directed mutagenesis (SDM) (QuikChange by Strategene). Primers 
are listed in Table 3.1. PdxS truncations and substitutions made at 291 and 292 were 
generated by sub-cloning, followed by insertion into an appropriate expression vector 
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using ligation independent cloning (LIC)104. Primers and expression vectors are listed in 
Table 3.2. 
Table 3:1 Primers and expression vectors for constructs generated by SDM.  
 
Table 3:2 Primers and expression vectors for constructs generated by sub-
cloning and LIC. 
 
Expression and Purification of PdxS and PdxT: 
PdxS and PdxT were expressed and purified separately. Cells of E. coli strain 
BL21(DE3) were transformed with the appropriate expression plasmid, grown at 37°C in 
Luria-Bertani (LB) medium until OD600 reached 0.8. The temperature was reduced to 
20°C for 1 hr, expression was induced with 400 µM isopropyl β-D-thiogalactopyranoside 
(IPTG), and cultures were incubated 12-16 hr. All purification steps were carried out at 
4°C unless otherwise noted. Cells from a 1L culture were harvested by centrifugation, 
PdxS R288A pET281 Forward 5'-TGTTGCCGGAGCACGCGATGCAAGAACGCG-3’ 
Plasmid Name Mutation
Expression 
Vector Direction Primer
pET0669_H169N PdxT H169N pET281 Forward 5'-TCGGCTGCTCGTTCAATCCAGAGCTGACC-3’
pET0881_R53K PdxS R53K pET281 Forward 5'-GCGCGTCCCGGCGGACATTAAGGCCGCTGGCG-3’
pET0881_R53E PdxS R53E pET281 Forward 5'-GCGTCCCGGCGGACATTGAGGCCGCTGGC-3’
pET0881_R53A PdxS R53A pET281 Forward 5'-GCGTCCCGGCGGACATTGCCGCCGCTGG-3’
pET0881_R53Q PdxS R53Q pET281 Forward 5'-CCGGCGGACATTCAGGCCGCTGGCGGT-3’
pET0881_E151S PdxS E151S pET281 Forward 5'-TCGATGTTGCGGACGAAAGGATCGCCGGGGACAG-3’
pET0881_E151A PdxS E151A pET281 Forward 5'-GGACGAAAGGAGCGCCGGGGACAGG-3’
pET0881_E151Q PdxS E151Q pET281 Forward 5'-TGTTGCGGACGAAAGGACAGCCGGGGA-3’
pET0881_R288K PdxS R288K pET281 Forward 5'-ATTGTTGCCGGAGCACAAGATGCAAGAACGCGGC-3’
pET0881_R288E PdxS R288E pET281 Forward 5'-TTGTTGCCGGAGCACGAGATGCAAGAACGCGG-3’
pET0881_R288Q PdxS R288Q pET281 Forward 5'-GTTGCCGGAGCACCAGATGCAAGAACGCG-3’ 
pET0881_R288A
Primers for SDM
Plasmid Name Start End Mutation
Expression 
Vector Direction Primer
pET0669_H169N PdxT H169N pET281 Forward 5'-TCGGCTGCTCGTTCAATCCAGAGCTGACC-3’
pET0881_R53K PdxS R53K pET281 Forward 5'-GCGCGTCCCGGCGGACATTAAGGCCGCTGGCG-3’
pET0881_R53E PdxS R53E pET281 Forward 5'-GCGTCCC C GACATTGAG CCGCTGGC-3’
pE R53A PdxS R53A pET281 Forward 5'-GCGTCCCG CGGAC TTGC GCCGCTGG-3’
p 53Q PdxS R53Q pET281 Forward 5'- CGGACATTCAG CCGCTGGC GT-3’
881_E151S PdxS E151S pET281 Forward 5'-TCGATGTTGCGGA AAG ATCGCCGG GACAG-3’
pET0881_E151A PdxS E151A pET281 Forward 5'-G ACGAAAGGA CGC GG GA AGG-3’
pET0881_E151Q PdxS E151Q pET281 Forward 5'-TGTTGCGGACGAAAGGACAGCCGGGGA-3’
pET0881_R288K PdxS R288K pET281 Forward 5'-ATTGTTGCCGGAGCACAAGATGCAAGAACGCGGC-3’
pET0881_R288E PdxS R288E pET281 Forward 5'-TTGTTGCCGGAGCACGAGATGCAAGAACGCGG-3’
pET0881_R288Q PdxS R288Q pET281 Forward 5'-GTTGCCGGAGCACCAGATGCAAGAACGCG-3’ 
pET0881_R288A PdxS R288A pET281 Forward 5'-TGTTGCCGGAGCACGCGATGCAAGAACGCG-3’ 
Plasmid Name Start End Mutation
Expression 
Vector Direction Primer
Forward  5'-TACTTCCAATCCAATGCAAGCACAGGTACGGAC-3’
pPdxSTail_270 3 270 pMCSG 7 Reverse 5'-TTATCCACTTCCAATGTTATCCTTTCGACAAGTGTGC-3’
pPdxSTail_278 3 278 pMCSG 7 Reverse 5'-TTATCCACTTCCAATGTTAGATGCCGCGCATCG-3’
pPdxSTail_286 3 286 pMCSG 7 Reverse 5'-TTATCCACTTCCAATGTTACTCCGGCAACAATGTC-3’
pPdxSTail_290 3 290 pMCSG 7 Reverse 5'-TTATCCACTTCCAATGTTATTGCATCCGGTGCT-3’
pPdxSTail_293 3 293 pMCSG 7 Reverse 5'-TTATCCACTTCCAATGTTAGCCGCGTTCTTGC-3’
pPdxS_E291D 3 PdxS E291D pMCSG 7 Reverse 5'-TTATCCACTTCCAATGTTACCAGCCGCGGTCTTGC-3'
pPdxS_E291Q 3 PdxS E291Q pMCSG 7 Reverse 5'-TTATCCACTTCCAATGTTACCAGCCGCGTTGTTGC-3'
pPdxS_E291A 3 PdxS E291A pMCSG 7 Reverse 5'-TTATCCACTTCCAATGTTACCAGCCGCGTGCTTGC-3'
pPdxS_R292K 3 PdxS R292K pMCSG 7 Reverse 5'-TTATCCACTTCCAATGTTACCAGCCTTTTTCTTGCATCCGGTG-3'
pPdxS_R292E 3 PdxS R292E pMCSG 7 Reverse 5'-TTATCCACTTCCAATGTTACCAGCCTTCTTCTTGCATCCGGTG-3'
pPdxS_R292Q 3 PdxS R292Q pMCSG 7 Reverse 5'-TTATCCACTTCCAATGTTACCAGCCCTGTTCTTGCATCCG-3'
pPdxS_R292A 3 PdxS R292A pMCSG 7 Reverse 5'-TTATCCACTTCCAATGTTACCAGCCTGCTTCTTGCATCCGGT-3'
Primers for SDM
Primers for LIC
PdxS START 3
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re-suspended in 40 mL of Buffer A (20 mM Tris-HCl pH 7.9, 500 mM NaCl), lysed by 
sonication, and centrifuged at 18,000 x g. The supernatant was filtered and loaded onto 
a Ni+2 affinity column (HisTrapTMHP, GE Healthcare). Bound protein was eluted with a 
linear gradient of 0-500 mM imidazole in Buffer A. The N-terminal His6-tag of PdxS was 
removed by TEV protease by 4 hr digestion at room temperature followed by dialysis 
(Buffer A). TEV protease and un-cleaved PdxS were removed by Ni+2 affinity 
chromatography. Proteins intended for crystallization were further purified by gel 
filtration. PdxS was purified on an S300 column (HiPrepTM 16/60 SephacrylTM S-300 HR, 
GE Healthcare) using 20 mM Tris-HCl pH 8.5, 500 mM NaCl, 10 mM glutamine, 2 mM 
DTT. PdxT was purified on an S100 column (HiPrepTM 16/60 SephacrylTM S-100 HR, 
GE Healthcare) using 20 mM Tris-HCl pH 7.9, 500 mM NaCl, 2 mM DTT. Intact PLPS 
was reconstituted by mixing PdxS and PdxT H169N in a 2:3 ratio in the presence of 10 
mM glutamine, purified by gel filtration (S300 column with 20 mM Tris-HCl pH 7.9, 500 
mM NaCl, 10 mM glutamine, 2 mM DTT), dialyzed (20 mM Tris-HCl pH 7.9, 10 mM 
glutamine) and stored at -80OC.  
PLPS Activity Assays: 
Glutaminase activity was assayed using a coupled reaction with glutamate 
dehydrogenase (GDH)8. Reactions were carried out at 37°C in a total reaction volume 
of 250 µL containing 50 µM PdxS, 50 µM PdxT, 100 mM Tris-HCl pH 8.5, 20 mM 
glutamine, 50 mM KCl, 0.375 mM 3-acetylpyridine adenine dinucleotide (APAD+) and 
1.8 µM GDH (Sigma). Glutamate formation was monitored by GDH reduction of APAD+ 
to APADH detected at 363 nm using a SpectraMax M5 Multi-Mode Microplate Reader 
(Molecular Devices).  
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Formation of the chromophoric adduct of R5P and NH3 with PdxS was assayed at 37°C 
in a total reaction volume of 50 µL containing 50 µM PdxS, 50 µM PdxT, 50 mM Tris-
HCl pH 7.9, 20 mM glutamine or 20mM (NH4)SO4 and 10mM R5P55. The chromophoric 
adduct was detected by absorbance at 315 nm in a SpectraMax M5.  
PLP synthesis was assayed at 37°C in a total reaction volume of 50 µL containing 50 
µM PdxS, 50 µM PdxT, 50 mM Tris-HCl pH 7.9, 20 mM glutamine, 10mM R5P, 20 mM 
G3P. PLP was detected by absorbance at 415 nm in a SpectraMax M5.  
For determination of kinetic constants, 1 µM PLPS was used and the reactions were 
carried out under the conditions stated above.  
Crystallization/Dehydration   
PLPS/H169NT/R5P/Gln was crystallized at 20°C by hanging drop vapor diffusion using 
1 µL of protein solution (7 mg/mL PLPS/H169NT, 20 mM Tris-HCl pH 7.9, 5 mM R5P, 
10 mM Gln) and 1 µL reservoir solution (14% PEG 3350, 200 mM Na malonate pH 7.0). 
Crystals appeared within 2 days, grew over 7 days, and were dehydrated by serial 
transfer of the cover slip to wells containing the original mother liquor with the PEG 
3350 concentration increased by 5% every 12 hours to a final concentration of 39%105. 
Crystals were directly flash-cooled in liquid nitrogen. Crystal dehydration resulted in a 
14% decrease in the unit cell volume (7,315,128 Å3 to 6,312,125 Å3) and an 
improvement in the diffraction limit from 3.9 Å to 2.69 Å.  
X-ray Data Collection and Processing: 
Data were collected at the Advanced Photon Source (APS) at the Argonne National 
laboratory on the GM/CA beam line 23ID-D. Data were processed and scaled with the 
HKL2000 suite (Table 3.3)91. Summaries of the crystallographic statistics are listed in 
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Table 3.4. Initial phases for PLPS/R5P/Gln was determined by molecular replacement 
(MR) using the program BALBES106 and the structures of PdxS48 (1ZNN) and PdxT9 
(2NV2). Iterative model building was done in COOT94 and refinement was carried out 
with REFMAC95 and Buster 107. TLS groups were determined using the webserver TLS 
MD96,97. Link records for PdxS Lys81-R5P and Cys78-Gln were created using J 
Ligand98. The restraints and coordinates for the Schiff base between PdxS Lys 81 and 
the thioester intermediate between PdxT Cys78 and glutamine (CYQ) were created 
using prodrg99 and the grade server100. The final model was validated with MolProbity 
(Fig. 3.3)101.  
Table 3:3 Scaling statistics for PLPS/H169NT/R5P/Gln.  
 
 	  
Lower Upper
50.00 7.32 922.1 66.1 0.526 0.044 3.3
7.32 5.81 295.2 21.9 0.671 0.053 3.4
5.81 5.08 277.9 21.1 0.742 0.060 3.4
5.08 4.62 381.8 29.1 0.888 0.065 3.4
4.62 4.29 363.3 28.0 1.256 0.084 3.4
4.29 4.03 293.5 23.5 1.030 0.083 3.4
4.03 3.83 237.7 20.5 1.067 0.088 3.4
3.83 3.66 191.1 17.8 1.214 0.105 3.4
3.66 3.52 163.7 16.4 1.042 0.111 3.4
3.52 3.40 125.5 14.4 1.083 0.138 3.4
3.40 3.30 105.5 13.4 1.134 0.164 3.3
3.30 3.20 81.5 12.4 1.193 0.208 3.3
3.20 3.12 64.5 11.8 1.174 0.251 3.2
3.12 3.04 57.9 11.7 1.203 0.282 3.2
3.04 2.97 41.8 10.9 1.260 0.381 3.2
2.97 2.91 35.6 10.8 1.250 0.438 3.2
2.91 2.85 33.1 10.8 1.216 0.464 3.2
2.85 2.80 27.9 10.7 1.262 0.560 3.1
2.80 2.75 25.8 10.7 1.240 0.601 3.1
2.75 2.70 22.7 10.7 1.315 0.687 3.1
188.7 18.7 1.081 0.101 3.3
Multiplicity
All Reflections
Shell Limit (Å) Average I Average Error Chi2 Linear R-factor
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Table 3:4 Crystallographic data and refinement statistics for 
PLPS/H169NT/R5P/Gln.  
 
 
PLPS/H169NT/R5P/Gln
Diffraction data
X-ray Source APS 23ID-D
wavelength 1.033
space group C2221
unit cell parameters (Å) 141.02, 249.14, 179.66
α, β, γ (°) 90, 90, 90
asymmetric unit 6 PdxS, 6 PdxT/H169N
resolution limit (Å) 2.69 (2.76-2.69)
unique reflections 87355
avg. I/σI 15.5(2.1)
avg. redundancy 3.3(3.1)
completeness (%) 98.9(98.9)
Rsym 0.101(0.695)
Refinement 
data range 50-2.69
Reflections 81715
R/Rfree (%) 20.9/25.7
RMS deviations
bonds lengths (Å) 0.0114
bond angles (deg) 1.4022
average B factors (Å2)
protein 59.5
water 40.5
ligands 62.7
Ramachandran
Favored (%) 96.3
Allowed(%) 3.2
Outlier (%) 0.5
Number of Atoms
Protein 21682
Water 263
Ligands 222
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Figure 3.3 Ramachandran plot for PLPS/H169NT/R5P/Gln. Ramachandran plots for 
PLPS/H169NT/R5P/Gln indicate that 96.4% of all residues were in favored regions 
and 99.5% of all residues were in allowed regions. Plots were generated using 
Molprobity101.  
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Results  
Kinetic characterization of PLPS from G. stearothermophilus. 
	   Several assays were used to evaluate PLPS activity, including glutamine 
hydrolysis by intact PLPS, chromophore formation by PLPS or PdxS, and PLP 
formation by PLPS and PdxS. Kinetic constants for PLPS were determined for all three 
substrates (Table 3.5). The Km values are similar to those published for Bacillus subtilis 
PLPS8,102. PLPS displayed Michaelis-Menten behavior with no detectable cooperativity. 
For most GATs the glutaminase activity is dependent on or accelerated by the synthase 
substrates108,109. This mode of regulation couples the two catalytic activities, efficiently 
generating ammonia only when the synthase substrates are present, thus preventing 
wasteful glutamine hydrolysis. In contrast, the glutaminase activity of PLPS was not 
dependent on or accelerated by R5P or G3P, but was dependent on formation of intact 
PLPS from the glutaminase subunit (PdxT) and the synthase subunit (PdxS). Under 
saturating conditions glutamine was hydrolyzed six times more quickly than PLP was 
synthesized. This discrepancy between the two active sites indicates that the 
glutaminase active site is not efficiently coupled to the synthase active site. This was 
previously shown in PLPS from B. subtilis8,9,54, and is confirmed here for PLPS from G. 
stearothermophilus. Although the synthase activities can be reconstituted using 
ammonia as a nitrogen source, the efficiency is 2-fold lower than with glutamine (Fig. 
3.4). This is also the case for Pdx1 from B. subtilis40,55.   
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Table 3:5 Kinetic constants for PLPS from G. stearothermophilus.
 
 	  
	  
Figure 3.4 Ammonium sulfate can substitute for PdxT and glutamine. Comparing 
wild type activity for chromophore formation to the activities of PLPS (T/H169N) 
in the presence of glutamine and R5P, PLPS (T/H169N) in the presence of AmSO4-
2 and R5P, PdxS in the presence of AmSO4-2 and R5P, and PdxS in the presence 
of R5P. 	  
Post crystal growth dehydration experiments increase resolution. 
Initial crystals of PLPS/H169NT co-crystallized with glutamine and R5P diffracted 
to 3.9Å. From this structure I were able to observe partial ordering of the C-terminal tail 
of PdxS. Density was present for the backbone and I could model the alpha carbons up 
to residue 290 (Fig. 3.5). Unfortunately, the density was too weak to confidently model 
the side chains. Confident that a higher resolution structure could be obtained, I 
attempted post crystal dehydration experiments. The objective was to decrease the 
Activity Variable Substrate Km (µM) kcat (µM/min) kcat/Km(µmol/min·mM)
glutaminase glutamine 600 ± 70 0.06 ± 0.001 0.1 ± 0.012
synthase G3P 1600 ± 400 0.01 ± 0.005 0.0063 ± 0.0016
synthase R5P 10 ± 2 0.01 ± 0.0003 1 ± 0.2
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